Velazquez, Emmanuel Rios <br/><br/>
Prediction of residual metabolic activity after treatment in NSCLC patients.  [electronic resource] 

 -  Acta oncologica (Stockholm, Sweden)  Oct 2010 
 - 1033-9 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1651-226X 
<br/><br/><label>Standard No.: </label>10.3109/0284186X.2010.498441  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--analysis<br/>Carcinoma, Non-Small-Cell Lung--diagnostic imaging<br/>Cell Survival<br/>Female<br/>Fluorodeoxyglucose F18<br/>Humans<br/>Lung Neoplasms--diagnostic imaging<br/>Male<br/>Middle Aged<br/>Neoplasm, Residual<br/>Positron-Emission Tomography--methods<br/>Prognosis<br/>Radiation-Sensitizing Agents--therapeutic use<br/>Radiotherapy, Conformal--methods<br/>Retrospective Studies<br/>Treatment Failure